title: Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine development.
abstract: Chlamydia trachomatis control efforts that enhance detection and treatment of infected women may paradoxically increase susceptibility of the population to infection. Conversely, these surveillance programs lower incidences of adverse sequelae elicited by genital tract infection (e.g., pelvic inflammatory disease and ectopic pregnancy), suggesting enhanced identification and eradication of C. trachomatis simultaneously reduces pathogen-induced upper genital tract damage and abrogates formation of protective immune responses. In this paper, we detail findings from C. trachomatis infection control programs that increase our understanding of chlamydial immunoepidemiology and discuss their implications for prophylactic vaccine design.
authors.affiliation: Department of Pediatrics, University of Pittsburgh School of Medicine, Rangos Research Center, Room 9123, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.
authors.forename: Jean M
authors.initials: JM
authors.lastname: Chavez
authors.forename: Rodolfo D
authors.initials: RD
authors.lastname: Vicetti Miguel
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Cherpes
mesh_terms: D001428:Bacterial Vaccines / Q000276:immunology* / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D002692:Chlamydia trachomatis / Q000276:immunology*; D005260:Female; D005831:Genital Diseases, Female / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D008403:Mass Screening; D011159:Population Surveillance; D011247:Pregnancy; D011248:Pregnancy Complications / Q000382:microbiology / Q000517:prevention & control
chemical_list: D001428:Bacterial Vaccines